A detailed history of Integrated Wealth Concepts LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 11,174 shares of EXEL stock, worth $465,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,174
Previous 14,402 22.41%
Holding current value
$465,397
Previous $634,000 27.29%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$36.22 - $46.25 $116,918 - $149,295
-3,228 Reduced 22.41%
11,174 $461,000
Q2 2025

Aug 14, 2025

BUY
$34.13 - $46.26 $491,540 - $666,236
14,402 New
14,402 $634,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.4B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.